Inventiva (IVA) Revenue & Revenue Breakdown
Inventiva Revenue Highlights
Latest Revenue (Y)
$17.50M
Latest Revenue (Q)
$15.58M
Main Geography (Y)
JAPAN
Inventiva Revenue by Period
Inventiva Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $17.50M | 43.69% |
2022-12-31 | $12.18M | 190.39% |
2021-12-31 | $4.19M | 1027.42% |
2020-12-31 | $372.00K | -94.68% |
2019-12-31 | $7.00M | 118.89% |
2018-12-31 | $3.20M | -50.97% |
2017-12-31 | $6.52M | -30.96% |
2016-12-31 | $9.45M | 93.77% |
2015-12-31 | $4.87M | 48.49% |
2014-12-31 | $3.28M | 7.13% |
2013-12-31 | $3.06M | - |
Inventiva Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2023-12-31 | $15.58M | 719.36% |
2023-06-30 | $1.90M | -84.30% |
2022-12-31 | $12.11M | 17977.61% |
2022-06-30 | $67.00K | -98.35% |
2021-12-31 | $4.05M | 6138.46% |
2021-06-30 | $65.00K | -12.16% |
2021-03-31 | $74.00K | -64.93% |
2020-12-31 | $211.00K | 185.14% |
2020-06-30 | $74.00K | -14.94% |
2020-03-31 | $87.00K | -98.46% |
2019-12-31 | $5.67M | 324.98% |
2019-06-30 | $1.33M | -23.81% |
2019-03-31 | $1.75M | -45.70% |
2018-12-31 | $3.22M | -22.49% |
2018-06-30 | $4.16M | 420.11% |
2018-03-31 | $799.25K | -84.77% |
2017-06-30 | $5.25M | 221.83% |
2017-03-31 | $1.63M | -65.35% |
2017-01-31 | $4.70M | -30.16% |
2016-06-30 | $6.74M | 185.26% |
2016-03-31 | $2.36M | -68.92% |
2016-01-31 | $7.60M | 523.38% |
2015-09-30 | $1.22M | -66.75% |
2015-06-30 | $3.66M | 200.73% |
2015-03-31 | $1.22M | -75.60% |
2015-01-31 | $5.00M | 508.64% |
2014-09-30 | $820.73K | - |
2014-06-30 | $820.73K | - |
2014-03-31 | $820.73K | - |
2014-01-31 | $820.73K | 7.13% |
2013-09-30 | $766.13K | - |
2013-06-30 | $766.13K | - |
2013-03-31 | $766.13K | - |
2013-01-31 | $766.13K | - |
Inventiva Revenue Breakdown
Inventiva Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 |
---|---|---|
China | $4.61M | $12.05M |
France | $118.00K | $125.00K |
JAPAN | $12.75M | - |
Inventiva Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
IMCR | Immunocore | $249.43M | $75.40M |
ACLX | Arcellx | $110.32M | $27.38M |
IPHA | Innate Pharma | $51.90M | $16.56M |
IVA | Inventiva | $17.50M | $15.58M |
NAMS | NewAmsterdam Pharma Company | $14.09M | $1.40M |
JANX | Janux Therapeutics | $8.08M | $1.25M |
VRCA | Verrica Pharmaceuticals | $5.12M | $3.83M |
HCWB | HCW Biologics | $2.84M | $618.85K |
INBX | Inhibrx Biosciences | $1.80M | - |
ANEB | Anebulo Pharmaceuticals | - | - |
RZLT | Rezolute | - | - |
CGEM | Cullinan Oncology | - | - |
LIAN | LianBio | - | - |
PCVX | Vaxcyte | - | - |
DICE | DICE Therapeutics | - | - |
ELYM | Eliem Therapeutics | - | - |
VTYX | Ventyx Biosciences | - | - |
MLYS | Mineralys Therapeutics | - | - |
VIGL | Vigil Neuroscience | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
CMPX | Compass Therapeutics | - | - |
EWTX | Edgewise Therapeutics | - | - |
IVA Revenue FAQ
What is Inventiva’s yearly revenue?
Inventiva's yearly revenue for 2023 was $17.5M, representing an increase of 43.69% compared to 2022. The company's yearly revenue for 2022 was $12.18M, representing an increase of 190.39% compared to 2021. IVA's yearly revenue for 2021 was $4.19M, representing an increase of 1027.42% compared to 2020.
What is Inventiva’s quarterly revenue?
Inventiva's quarterly revenue for Q4 2023 was $15.58M, a 719.36% increase from the previous quarter (Q2 2023), and a 284.12% increase year-over-year (Q4 2021). The company's quarterly revenue for Q2 2023 was $1.9M, a -84.30% decrease from the previous quarter (Q4 2022), and a 2824.62% increase year-over-year (Q2 2021). IVA's quarterly revenue for Q4 2022 was $12.11M, a 17977.61% increase from the previous quarter (Q2 2022), and a 16267.57% increase year-over-year (Q1 2021).
What is Inventiva’s revenue growth rate?
Inventiva's revenue growth rate for the last 3 years (2021-2023) was 317.26%, and for the last 5 years (2019-2023) was 150.07%.